Director / Editor: Victor Teboul, Ph.D.

Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.

The TGA has approved donanemab for Alzheimer’s disease. How does this drug work and who will be able to access it?

By Steve Macfarlane, Head of Clinical Services, Dementia Support Australia, & Associate Professor of Psychiatry, Monash University

Donanemab is only for use in the early stages of Alzheimer’s disease. And for now at least, it comes with a hefty price tag.

Read complete article

~	Ethiopia: Authorities must engage in negotiations with striking healthcare professionals, unconditionally release detained medics

~	Aid teams highlight growing anxiety in Gaza after food is looted

~	Do shorter prison sentences make society less safe? What the evidence says

~	Five ways to inspire ocean connection: reflections from my 40-year marine ecology career

~	West Nile virus found in the UK for the first time – what you need to know

~	What’s it like being a raven or a crow?

~	Oscar Wilde’s The Ballad of Reading Gaol is a work of art activism beloved by Banksy

~	View from The Hill: Coalition is being glued together again after crisis week

~	A First Nations writer’s fellowship was withdrawn by Queensland’s government. What’s going on?

~	Michelle de Kretser wins the Stella Prize with a genre-bending questioning of art and expectation